Related Content
Search Google Scholar for:
More Information
Related Jobs from ScienceCareers
|
|
Science 14 May 1999: Vol. 284. no. 5417, pp. 1183 - 1187 DOI: 10.1126/science.284.5417.1183
|
|
Reports
Control of Autoimmune Diabetes in NOD Mice by GAD Expression or Suppression in Cells
Ji-Won Yoon,
123*
Chang-Soon Yoon,
1
Hye-Won Lim,
1
Qi Quan Huang,
1
Yup Kang,
2
Kwang Ho Pyun,
4
Kensuke Hirasawa,
1
Robert S. Sherwin,
3
Hee-Sook Jun
1
Glutamic acid decarboxylase (GAD) is a pancreatic cell
autoantigen in humans and nonobese diabetic (NOD) mice. Cell-specific suppression of GAD expression in two lines of antisense
GAD transgenic NOD mice prevented autoimmune diabetes, whereas
persistent GAD expression in the cells in the other four lines of
antisense GAD transgenic NOD mice resulted in diabetes, similar to that seen in transgene-negative NOD mice. Complete suppression of cell
GAD expression blocked the generation of diabetogenic T cells and
protected islet grafts from autoimmune injury. Thus, cell-specific GAD expression is required for the development of autoimmune diabetes in NOD mice, and modulation of GAD might, therefore, have therapeutic value in type 1 diabetes.
1 Laboratory of Viral and Immunopathogenesis of
Diabetes, Julia McFarlane Diabetes Research Centre and Department of
Microbiology and Infectious Diseases, Faculty of Medicine, University
of Calgary, Calgary, Alberta T2N 4N1, Canada.
2 Laboratory of Endocrinology, Institute for Medical
Science, Department of Endocrinology and Metabolism, School of
Medicine, Ajou University, San 5, Wonchon-dong, Paldal-gu, Suwon
442-749, Korea.
3 Diabetes Endocrinology Research
Center, School of Medicine, Yale University, 333 Cedar Street, New
Haven, CT 06520-8020, USA.
4 Korea Research
Institute of Bioscience and Biotechnology, 52 Eueon-dong, Yusong-ku,
Taejon 305-333, Korea.
*
To whom correspondence should be addressed. E-mail:
yoon{at}ucalgary.ca
Read the Full Text
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice.
- W. Truong, W. W. Hancock, J. C. Plester, S. Merani, D. C. Rayner, G. Thangavelu, K. M. Murphy, C. C. Anderson, and A. M. J. Shapiro (2009)
J. Leukoc. Biol.
86, 41-51
| Abstract »
| Full Text »
| PDF »
- Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice.
- J. A. Emamaullee, J. Davis, S. Merani, C. Toso, J. F. Elliott, A. Thiesen, and A.M. J. Shapiro (2009)
Diabetes
58, 1302-1311
| Abstract »
| Full Text »
| PDF »
- A possible role of osteocalcin in the regulation of insulin secretion: human in vivo evidence?.
- E. Kassi and A. G Papavassiliou (2008)
J. Endocrinol.
199, 151-153
| Abstract »
| Full Text »
| PDF »
- Activating Fc{gamma} Receptors Participate in the Development of Autoimmune Diabetes in NOD Mice.
- Y. Inoue, T. Kaifu, A. Sugahara-Tobinai, A. Nakamura, J.-I. Miyazaki, and T. Takai (2007)
J. Immunol.
179, 764-774
| Abstract »
| Full Text »
| PDF »
- A novel approach to ultrasensitive diagnosis using supramolecular protein nanoparticles.
- S.-H. Lee, H. Lee, J.-S. Park, H. Choi, K.-Y. Han, H.-S. Seo, K.-Y. Ahn, S.-S. Han, Y. Cho, K.-H. Lee, et al. (2007)
FASEB J
21, 1324-1334
| Abstract »
| Full Text »
| PDF »
- Minimal Impact of a De Novo-Expressed {beta}-Cell Autoantigen on Spontaneous Diabetes Development in NOD Mice.
- M. M. Martinic, A. E. Juedes, D. Bresson, D. Homann, K. Skak, C. Huber, E. Ling, M. Ejrnaes, T. Wolfe, L. Togher, et al. (2007)
Diabetes
56, 1059-1068
| Abstract »
| Full Text »
| PDF »
- T cells to a dominant epitope of GAD65 express a public CDR3 motif.
- A. Quinn, M. McInerney, D. Huffman, B. McInerney, S. Mayo, K. Haskins, and E. Sercarz (2006)
Int. Immunol.
18, 967-979
| Abstract »
| Full Text »
| PDF »
- Role of {beta}-Cells in Type 1 Diabetes Pathogenesis.
- B. Faideau, E. Larger, F. Lepault, J. C. Carel, and C. Boitard (2005)
Diabetes
54, S87-S96
| Abstract »
| Full Text »
| PDF »
- A Peptide of Glutamic Acid Decarboxylase 65 Can Recruit and Expand a Diabetogenic T Cell Clone, BDC2.5, in the Pancreas.
- Y. D. Dai, K. P. Jensen, A. Lehuen, E. L. Masteller, J. A. Bluestone, D. B. Wilson, and E. E. Sercarz (2005)
J. Immunol.
175, 3621-3627
| Abstract »
| Full Text »
| PDF »
- Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.
- S.-K. Kim, K. V. Tarbell, M. Sanna, M. Vadeboncoeur, T. Warganich, M. Lee, M. Davis, and H. O. McDevitt (2004)
PNAS
101, 14204-14209
| Abstract »
| Full Text »
| PDF »
- Diabetes Incidence Is Unaltered in Glutamate Decarboxylase 65-Specific TCR Retrogenic Nonobese Diabetic Mice: Generation by Retroviral-Mediated Stem Cell Gene Transfer.
- P. Y. Arnold, A. R. Burton, and D. A. A. Vignali (2004)
J. Immunol.
173, 3103-3111
| Abstract »
| Full Text »
| PDF »
- Differential Regulation of Islet-specific Glucose-6-phosphatase Catalytic Subunit-related Protein Gene Transcription by Pax-6 and Pdx-1.
- C. C. Martin, J. K. Oeser, and R. M. O'Brien (2004)
J. Biol. Chem.
279, 34277-34289
| Abstract »
| Full Text »
| PDF »
- Immunoregulatory Role of Nitric Oxide in Kilham Rat Virus-Induced Autoimmune Diabetes in DR-BB Rats.
- I. I. Mendez, Y.-H. Chung, H.-S. Jun, and J.-W. Yoon (2004)
J. Immunol.
173, 1327-1335
| Abstract »
| Full Text »
| PDF »
- The Proximal Islet-Specific Glucose-6-Phosphatase Catalytic Subunit-Related Protein Autoantigen Promoter Is Sufficient to Initiate but not Maintain Transgene Expression in Mouse Islets in Vivo.
- C. Frigeri, C. C. Martin, C. A. Svitek, J. K. Oeser, J. C. Hutton, M. Gannon, and R. M. O'Brien (2004)
Diabetes
53, 1754-1764
| Abstract »
| Full Text »
| PDF »
- Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4.
- S. Ma, Y. Huang, Z. Yin, R. Menassa, J. E. Brandle, and A. M. Jevnikar (2004)
PNAS
101, 5680-5685
| Abstract »
| Full Text »
| PDF »
- Regulated Exocytosis of GABA-containing Synaptic-like Microvesicles in Pancreatic {beta}-cells.
- M. Braun, A. Wendt, B. Birnir, J. Broman, L. Eliasson, J. Galvanovskis, J. Gromada, H. Mulder, and P. Rorsman (2004)
J. Gen. Physiol.
123, 191-204
| Abstract »
| Full Text »
| PDF »
- GABA in the Endocrine Pancreas: Its Putative Role as an Islet Cell Paracrine-signalling Molecule.
- I. K. Franklin and C. B. Wollheim (2004)
J. Gen. Physiol.
123, 185-190
| Full Text »
| PDF »
- Transplantation of Reversibly Immortalized Insulin-Secreting Human Hepatocytes Controls Diabetes in Pancreatectomized Pigs.
- T. Okitsu, N. Kobayashi, H.-S. Jun, S. Shin, S.-J. Kim, J. Han, H. Kwon, M. Sakaguchi, T. Totsugawa, M. Kohara, et al. (2004)
Diabetes
53, 105-112
| Abstract »
| Full Text »
| PDF »
- The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice.
- M. J. I. Ansari, A. D. Salama, T. Chitnis, R. N. Smith, H. Yagita, H. Akiba, T. Yamazaki, M. Azuma, H. Iwai, S. J. Khoury, et al. (2003)
J. Exp. Med.
198, 63-69
| Abstract »
| Full Text »
| PDF »
- Normal Incidence of Diabetes in NOD Mice Tolerant to Glutamic Acid Decarboxylase.
- E. Jaeckel, L. Klein, N. Martin-Orozco, and H. von Boehmer (2003)
J. Exp. Med.
197, 1635-1644
| Abstract »
| Full Text »
| PDF »
- Fetal or Neonatal Low-Glycotoxin Environment Prevents Autoimmune Diabetes in NOD Mice.
- M. Peppa, C. He, M. Hattori, R. McEvoy, F. Zheng, and H. Vlassara (2003)
Diabetes
52, 1441-1448
| Abstract »
| Full Text »
| PDF »
- Modulation of Glucocorticoid-Induced GAD Expression in Pancreatic {beta}-Cells by Transcriptional Activation of the GAD67 Promoter and Its Possible Effect on the Development of Diabetes.
- K. S. Kim, Y. Kang, S. E. Choi, J. H. Kim, H. M. Kim, B. Sun, H.-S. Jun, and J.-W. Yoon (2002)
Diabetes
51, 2764-2772
| Abstract »
| Full Text »
| PDF »
- A Comprehensive, Statistically Powered Analysis of GAD2 in Type 1 Diabetes.
- G. C.L. Johnson, F. Payne, S. Nutland, H. Stevens, E. Tuomilehto-Wolf, J. Tuomilehto, and J. A. Todd (2002)
Diabetes
51, 2866-2870
| Abstract »
| Full Text »
| PDF »
- T Cell Response to Preproinsulin I and II in the Nonobese Diabetic Mouse.
- P. Halbout, J.-P. Briand, C. Becourt, S. Muller, and C. Boitard (2002)
J. Immunol.
169, 2436-2443
| Abstract »
| Full Text »
| PDF »
- CD4+ T Cells from Glutamic Acid Decarboxylase (GAD)65-specific T Cell Receptor Transgenic Mice Are Not Diabetogenic and Can Delay Diabetes Transfer.
- K. V. Tarbell, M. Lee, E. Ranheim, C. C. Chao, M. Sanna, S.-K. Kim, P. Dickie, L. Teyton, M. Davis, and H. McDevitt (2002)
J. Exp. Med.
196, 481-492
| Abstract »
| Full Text »
| PDF »
- Detection of GAD65-Specific T-Cells by Major Histocompatibility Complex Class II Tetramers in Type 1 Diabetic Patients and At-Risk Subjects.
- H. Reijonen, E. J. Novak, S. Kochik, A. Heninger, A. W. Liu, W. W. Kwok, and G. T. Nepom (2002)
Diabetes
51, 1375-1382
| Abstract »
| Full Text »
| PDF »
- Prodigiosin Blocks T Cell Activation by Inhibiting Interleukin-2Ralpha Expression and Delays Progression of Autoimmune Diabetes and Collagen-Induced Arthritis.
- S. B. Han, S. H. Park, Y. J. Jeon, Y. K. Kim, H. M. Kim, and K. H. Yang (2001)
J. Pharmacol. Exp. Ther.
299, 415-425
| Abstract »
| Full Text »
| PDF »
- Plasmid Vaccination with Insulin B Chain Prevents Autoimmune Diabetes in Nonobese Diabetic Mice.
- A. Bot, D. Smith, S. Bot, A. Hughes, T. Wolfe, L. Wang, C. Woods, and M. v. Herrath (2001)
J. Immunol.
167, 2950-2955
| Abstract »
| Full Text »
| PDF »
- MHC Class I-Restricted Determinants on the Glutamic Acid Decarboxylase 65 Molecule Induce Spontaneous CTL Activity.
- A. Quinn, M. F. McInerney, and E. E. Sercarz (2001)
J. Immunol.
167, 1748-1757
| Abstract »
| Full Text »
| PDF »
- The Frequency of High Avidity T Cells Determines the Hierarchy of Determinant Spreading.
- J. Tian, S. Gregori, L. Adorini, and D. L. Kaufman (2001)
J. Immunol.
166, 7144-7150
| Abstract »
| Full Text »
| PDF »
- Environmental Modulation of Autoimmune Arthritis Involves the Spontaneous Microbial Induction of T Cell Responses to Regulatory Determinants Within Heat Shock Protein 65.
- K. D. Moudgil, E. Kim, O. J. Yun, H. H. Chi, E. Brahn, and E. E. Sercarz (2001)
J. Immunol.
166, 4237-4243
| Abstract »
| Full Text »
| PDF »
- Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C.
- B Wesche, E Jaeckel, C Trautwein, H Wedemeyer, A Falorni, H Frank, A von zur Muhlen, M-P Manns, and G Brabant (2001)
Gut
48, 378-383
| Abstract »
| Full Text »
| PDF »
- Regulatory and Effector CD4 T Cells in Nonobese Diabetic Mice Recognize Overlapping Determinants on Glutamic Acid Decarboxylase and Use Distinct V{{beta}} Genes.
- A. Quinn, B. McInerney, E. P. Reich, O. Kim, K. P. Jensen, and E. E. Sercarz (2001)
J. Immunol.
166, 2982-2991
| Abstract »
| Full Text »
| PDF »
- Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65).
- G. T. Nepom, J. D. Lippolis, F. M. White, S. Masewicz, J. A. Marto, A. Herman, C. J. Luckey, B. Falk, J. Shabanowitz, D. F. Hunt, et al. (2001)
PNAS
98, 1763-1768
| Abstract »
| Full Text »
| PDF »
- Cerebellar Ataxia With Anti-Glutamic Acid Decarboxylase Antibodies: Study of 14 Patients.
- J. Honnorat, A. Saiz, B. Giometto, A. Vincent, L. Brieva, C. de Andres, J. Maestre, N. Fabien, A. Vighetto, R. Casamitjana, et al. (2001)
Arch Neurol
58, 225-230
| Abstract »
| Full Text »
| PDF »
- Identification of MHC Class II-Restricted Peptide Ligands, Including a Glutamic Acid Decarboxylase 65 Sequence, that Stimulate Diabetogenic T Cells from Transgenic BDC2.5 Nonobese Diabetic Mice.
- V. Judkowski, C. Pinilla, K. Schroder, L. Tucker, N. Sarvetnick, and D. B. Wilson (2001)
J. Immunol.
166, 908-917
| Abstract »
| Full Text »
| PDF »
- Early Th1 Response in Unprimed Nonobese Diabetic Mice to the Tyrosine Phosphatase-Like Insulinoma-Associated Protein 2, an Autoantigen in Type 1 Diabetes.
- S. Trembleau, G. Penna, S. Gregori, G. Magistrelli, A. Isacchi, and L. Adorini (2000)
J. Immunol.
165, 6748-6755
| Abstract »
| Full Text »
| PDF »
- Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers.
- C.-P. Liu, K. Jiang, C.-H. Wu, W.-H. Lee, and W.-J. Lin (2000)
PNAS
| Abstract »
| Full Text »
- The I-Ag7 MHC Class II Molecule Linked to Murine Diabetes Is a Promiscuous Peptide Binder.
- T. Stratmann, V. Apostolopoulos, V. Mallet-Designe, A. L. Corper, C. A. Scott, I. A. Wilson, A. S. Kang, and L. Teyton (2000)
J. Immunol.
165, 3214-3225
| Abstract »
| Full Text »
| PDF »
- Increased expression of GAD65 and GABA in pancreatic beta -cells impairs first-phase insulin secretion.
- Y. Shi, J. Kanaani, V. Menard-Rose, Y. H. Ma, P.-Y. Chang, D. Hanahan, A. Tobin, G. Grodsky, and S. Baekkeskov (2000)
Am J Physiol Endocrinol Metab
279, E684-E694
| Abstract »
| Full Text »
| PDF »
- Alternative Splicing of GAD67 Results in the Synthesis of a Third Form of Glutamic-acid Decarboxylase in Human Islets and Other Non-neural Tissues.
- S. D. Chessler and A. Lernmark (2000)
J. Biol. Chem.
275, 5188-5192
| Abstract »
| Full Text »
| PDF »
- Control of Autoimmune Diabetes.
- M. Atkinson, T. Ellis, D. Serreze;, J. Tian, D. L. Kaufman;, J. W. Yoon, H. W. Lim, K. Hirasawa, R. S. Sherwin, and H. S. Jun; (2000)
Science
287, 191a-191
| Full Text »
- Autoantibody Recognition of COOH-Terminal Epitopes of GAD65 Marks the Risk for Insulin Requirement in Adult-Onset Diabetes Mellitus.
- A. Falorni, G. Gambelunghe, F. Forini, G. Kassi, A. Cosentino, P. Candeloro, G. B. Bolli, P. Brunetti, and F. Calcinaro (2000)
J. Clin. Endocrinol. Metab.
85, 309-316
| Abstract »
| Full Text »
- Autoantigen May Trigger Type 1 Diabetes.
- (1999)
Journal Watch (General)
1999, 4
| Full Text »
- Grafts of supplementary thymuses injected with allogeneic pancreatic islets protect nonobese diabetic mice against diabetes.
- J. Salaun, N. Simmenauer, P. Belo, A. Coutinho, and N. M. Le Douarin (2002)
PNAS
99, 874-877
| Abstract »
| Full Text »
| PDF »
- Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers.
- C.-P. Liu, K. Jiang, C.-H. Wu, W.-H. Lee, and W.-J. Lin (2000)
PNAS
97, 14596-14601
| Abstract »
| Full Text »
| PDF »
|
|